Abstract
Angiogenesis plays a central role in the progression of both solid and hematologic tumors. We have focused our attention on multiple myeloma (MM) and on bone marrow stromal cells. These, in fact, both support tumor cell survival and participate in angiogenesis by releasing a broad number of angiogenic cytokines. Macrophages and mast cells may participate in this process through other mechanisms, such as vasculogenic mimicry. Lastly, it has been shown that hematopoietic stem and progenitor cells (HSPCs) are involved in vasculogenesis in MM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2004) Monocytes and macrophages form branched cell columns in matrigel: implications for their role in neovascularization. Stem Cells Dev 13:665–676
Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2006) Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168:529–541
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow. Lancet 357:539–545
Bellamy WT, Richter L, Frutiger Y, Grogan TM (1999) Expression of vascular endothelial growth factor and its receptors in hematological malignancies. Blood 59:728–733
Coluccia AML, Cirulli T, Neri P, Mangieri D, Colanardi MC, Gnoni A, Di Renzo N, Tassone P, Ribatti D, Dammacco F, Gambacorti-Passerini C, Vacca A (2008) Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib (BMS-354825/Sprycel®). Blood 112:1346–1356
Crivellato E, Nico B, Ribatti D (2008) Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 269:1–6
Di Raimondo F, Azzaro MP, Palombo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R (2000) Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85:800–805
Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkiewicz J, Elsasser HP, Muller R, Havemann K (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287–300
Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate re-endothelization as endothelial progenitor cells. Circ Res 93:980–989
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585–598
Klimp AH, Hollema H, Kempinga C, van der Zee AG, De Vries EG, Daemen T (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7305–7309
Kumar S, Witzig TE, Timm M, Huang J, Wellik L, Kimlinger TK, Griepp PR, Rajkumar SV (2004) Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favouring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104:1159–1165
Lewis CE, Leek R, Harris A, Mc Gee JO (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57:747–751
Mangieri D, Nico B, Benagiano V, De Giorgis M, Vacca A, Ribatti D (2008) Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin. J Cell Mol Med 12:1023–1028
Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752
Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265–270
Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy E (2000) Contribution of moncytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87:378–384
Nakayama T, Yao L, Tosato G (2004) Mast cell-derived angiopoietin-1 plays a role in the growth of plasma cell tumors. J Clin Invest 114:1317–1325
Nico B, Mangieri D, Crivellato E, Vacca A, Ribatti D (2008) Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 17:19–22
Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164–1169
Ria R, Piccoli C, Cirulli T, Falzetti F, Mangialardi G, Guidolin D, Tabilio A, Di Renzo N, Guarini A, Ribatti D, Dammacco F, Vacca A (2008) Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma. Clin Cancer Res 14:1678–1685
Ribatti D (2007) The discovery of endothelial progenitor cells. An historical review. Leuk Res 31:439–444
Ribatti D, Vacca A (2008) Angiogenesis and anti-angiogenesis in haematological diseases. MEMO 1:31–33
Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L, Dammacco F (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451–455
Ribatti D, Vacca A, Dammacco F (2003) New non-angiogenesis dependent pathways for tumor growth. Eur J Cancer 39:1835–1841
Ribatti D, Crivellato E, Roccaro AM, Ria R, Vacca A (2004) Mast cell contribution to angiogenesis related to tumor progression. Clin Exp Allergy 34:1660–1664
Ribatti D, Nico B, Crivellato E, Vacca A (2005) Endothelial progenitor cells in health and disease. Histol Histopathol 20:1351–1358
Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25:4257–4266
Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A (2007) The history of the angiogenic switch concept. Leukemia 21:44–52
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
Risau W, Lemmon D (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73–91
Scavelli C, Nico B, Cirulli T, Ria R, Di Pietro G, Mangieri D, Bacigalupo A, Mangialardi G, Coluccia AML, Caravita T, Molica S, Ribatti D, Dammacco F, Vacca A (2008) Vasculogenic mimicry by bone marrow macrophages in patient with multiple myeloma. Oncogene 27:663–674
Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, Daniel WG (2001) Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel® under angiogenic conditions. Cardiovasc Res 49:671–680
Sunderkotter C, Goebeler M, Schiltze-Osthoff K, Bhardway R, Sorg C (1991) Macrophages-derived angiogenesis factors. Pharmacol Ther 51:195–216
Theoharides TC, Conti P (2004) Mast cells: the Jeckyll and Hyde of tumor growth. Trends Immunol 25:235–241
Vacca A, Ribatti D (2006) Bone marrow angiogenesis in multiple myeloma. Leukemia 20: 193–199
Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503–508
Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F (1999) Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93:3064–3073
Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico B, Gernone A, Bottelli F, Tabilio A, Guidolin D, Petrucci MT, Ribatti D, Dammacco F (2003) Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340–3348
Vacca A, Scavelli C, Montefusco V, Di Pietro G, Neri A, Mattioli M, Bicciato S, Nico B, Ribatti D, Dammacco F, Corradini P (2005) Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol 23:5334–5346
Zhao Y, Glesne D, Huberman E (2003) A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100:2426–2431
Acknowledgments
This work was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan; the Ministry of Education, University and Research (MIUR, PRIN Projects 2007), Rome; the Ministry of Health, Progetto Oncologia 2006, Rome; Humanitas Mirasole S.p.A., Rome; Fondazione Cassa di Risparmio di Puglia, Bari, Italy.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vacca, A., Ribatti, D. (2011). Angiogenesis and Vasculogenesis in Multiple Myeloma: Role of Inflammatory Cells. In: Moehler, T., Goldschmidt, H. (eds) Multiple Myeloma. Recent Results in Cancer Research, vol 183. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85772-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-85772-3_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85771-6
Online ISBN: 978-3-540-85772-3
eBook Packages: MedicineMedicine (R0)